Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Lippard

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Biochemistry|July 2, 1998
NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatinA Gelasco, S J Lippard
Journal of the American Chemical Society|July 18, 2001
Oxidative N-dealkylation of a carboxylate-bridged diiron(II) precursor complex by reaction with O2 affords the elusive [Fe2(mu-OH)2(mu-O2CR)](3+) core of soluble methane monooxygenase hydroxylaseD Lee, S J Lippard
Biochemistry|February 20, 1996
Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteinsS A Kane, S J Lippard
Biochemistry|June 12, 1979
Cooperative binding of a platinum metallointercalation reagent to poly(A).poly(U)J K Barton, S J Lippard
Science (New York, N.Y.)|April 10, 1992
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatinP M Pil, S J Lippard
Nature|February 20, 1986
A new synthetic approach to the ferritin core uncovers the soluble iron(III) oxo-hydroxo aggregate [Fe11O6(OH)6(O2CPh)15]S M Gorun, S J Lippard
Biochemistry|September 23, 1997
DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNAS U Dunham, S J Lippard
Inorganic Chemistry|February 24, 2001
Nitrosyl transfer from manganese to iron in tropocoronand complexesK J Franz, S J Lippard
Nucleic Acids Research|May 1, 1974
Mercury(II) binding to s4U in E. coli tRNA(Val)H R Sunshine, S J Lippard
Inorganic Chemistry|March 22, 2001
Phthalazine-based dinucleating ligands afford dinuclear centers often encountered in metalloenzyme active sitesA M Barrios, S J Lippard
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Biochemistry|July 2, 1998
NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatinA Gelasco, S J Lippard
Journal of the American Chemical Society|July 18, 2001
Oxidative N-dealkylation of a carboxylate-bridged diiron(II) precursor complex by reaction with O2 affords the elusive [Fe2(mu-OH)2(mu-O2CR)](3+) core of soluble methane monooxygenase hydroxylaseD Lee, S J Lippard
Biochemistry|February 20, 1996
Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteinsS A Kane, S J Lippard
Biochemistry|June 12, 1979
Cooperative binding of a platinum metallointercalation reagent to poly(A).poly(U)J K Barton, S J Lippard
Science (New York, N.Y.)|April 10, 1992
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatinP M Pil, S J Lippard
Nature|February 20, 1986
A new synthetic approach to the ferritin core uncovers the soluble iron(III) oxo-hydroxo aggregate [Fe11O6(OH)6(O2CPh)15]S M Gorun, S J Lippard
Biochemistry|September 23, 1997
DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNAS U Dunham, S J Lippard
Inorganic Chemistry|February 24, 2001
Nitrosyl transfer from manganese to iron in tropocoronand complexesK J Franz, S J Lippard
Nucleic Acids Research|May 1, 1974
Mercury(II) binding to s4U in E. coli tRNA(Val)H R Sunshine, S J Lippard
Inorganic Chemistry|March 22, 2001
Phthalazine-based dinucleating ligands afford dinuclear centers often encountered in metalloenzyme active sitesA M Barrios, S J Lippard
Pageof 15